ATE405263T1 - Anti-hiv-chinuklidinverbindungen - Google Patents
Anti-hiv-chinuklidinverbindungenInfo
- Publication number
- ATE405263T1 ATE405263T1 AT05857423T AT05857423T ATE405263T1 AT E405263 T1 ATE405263 T1 AT E405263T1 AT 05857423 T AT05857423 T AT 05857423T AT 05857423 T AT05857423 T AT 05857423T AT E405263 T1 ATE405263 T1 AT E405263T1
- Authority
- AT
- Austria
- Prior art keywords
- infectivity
- hiv
- mammal
- quinuclidine compounds
- benzoylquinuclidine
- Prior art date
Links
- 230000036436 anti-hiv Effects 0.000 title 1
- SBYHFKPVCBCYGV-UHFFFAOYSA-N quinuclidine Chemical class C1CC2CCN1CC2 SBYHFKPVCBCYGV-UHFFFAOYSA-N 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 2
- 230000001717 pathogenic effect Effects 0.000 abstract 2
- 238000002560 therapeutic procedure Methods 0.000 abstract 2
- DNDSUVVGUXQWAH-UHFFFAOYSA-N 1-azabicyclo[2.2.2]octan-2-yl(phenyl)methanone Chemical class C1C(CC2)CCN2C1C(=O)C1=CC=CC=C1 DNDSUVVGUXQWAH-UHFFFAOYSA-N 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 210000004962 mammalian cell Anatomy 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 241001430294 unidentified retrovirus Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55955004P | 2004-04-05 | 2004-04-05 | |
| US59020904P | 2004-07-22 | 2004-07-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE405263T1 true ATE405263T1 (de) | 2008-09-15 |
Family
ID=36793472
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05857423T ATE405263T1 (de) | 2004-04-05 | 2005-04-01 | Anti-hiv-chinuklidinverbindungen |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20080194619A1 (de) |
| EP (1) | EP1732547B1 (de) |
| JP (1) | JP2007531792A (de) |
| AT (1) | ATE405263T1 (de) |
| AU (1) | AU2005327283A1 (de) |
| CA (1) | CA2563109A1 (de) |
| DE (1) | DE602005009158D1 (de) |
| WO (1) | WO2006085890A2 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2014115979A (ru) * | 2011-09-22 | 2015-10-27 | Вертекс Фармасьютикалз Инкорпорейтед | Соединения, используемые как ингибиторы холинкиназы |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2527211A1 (en) * | 2003-06-02 | 2004-12-16 | Samaritan Pharmaceuticals, Inc. | Anti-hiv benzamide compounds |
| AR050902A1 (es) * | 2004-04-27 | 2006-12-06 | Glaxo Group Ltd | Compuesto de quinuclidina, composicion farmaceutica que lo comprende y su usopara preparar dicha composicion |
-
2005
- 2005-04-01 AT AT05857423T patent/ATE405263T1/de not_active IP Right Cessation
- 2005-04-01 AU AU2005327283A patent/AU2005327283A1/en not_active Abandoned
- 2005-04-01 CA CA002563109A patent/CA2563109A1/en not_active Abandoned
- 2005-04-01 WO PCT/US2005/011372 patent/WO2006085890A2/en not_active Ceased
- 2005-04-01 DE DE602005009158T patent/DE602005009158D1/de not_active Expired - Fee Related
- 2005-04-01 EP EP05857423A patent/EP1732547B1/de not_active Expired - Lifetime
- 2005-04-01 JP JP2007507405A patent/JP2007531792A/ja active Pending
- 2005-04-01 US US10/599,704 patent/US20080194619A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2563109A1 (en) | 2006-08-17 |
| WO2006085890A3 (en) | 2006-12-07 |
| WO2006085890A2 (en) | 2006-08-17 |
| JP2007531792A (ja) | 2007-11-08 |
| AU2005327283A1 (en) | 2006-08-17 |
| EP1732547B1 (de) | 2008-08-20 |
| US20080194619A1 (en) | 2008-08-14 |
| EP1732547A2 (de) | 2006-12-20 |
| DE602005009158D1 (de) | 2008-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021009269A (es) | Inhibidores de enpp1 y metodos para modular una respuesta inmunitaria. | |
| CY1119001T1 (el) | Ενωσεις 1,2,4-οξαδιαζολο βενζοϊκου οξεος και χρηση αυτων για ανευ νοηματος καταστολη και τη θεραπεια ασθενειας | |
| RU2013121788A (ru) | Ингибиторы репликации вич | |
| EA201790406A1 (ru) | Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения | |
| BR112015009504A2 (pt) | inibidores de rock | |
| AR067903A1 (es) | Metodo para tratar la depresion mediada por estres | |
| AR085662A1 (es) | Metodos y composiciones para tratar la hiperuricemia y trastornos metabolicos asociados con la hiperuricemia | |
| AR082803A1 (es) | Metodos y formulaciones para el tratamiento de la trombosis con betrixaban y un inhibidor de la glicoproteina p | |
| NZ592615A (en) | Method for treating or preventing thrombosis using 150 mg b.i.d. of dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy | |
| MX365007B (es) | Uso de acido lipasa lisosomal para tratar la dificiencia de acido lipasa lisosomal en pacientes. | |
| EA201491460A1 (ru) | ПРИМЕНЕНИЕ ЛАХИНИМОДА В ЛЕЧЕНИИ ПАЦИЕНТОВ С БОЛЕЗНЬЮ КРОНА, У КОТОРЫХ НЕ ЭФФЕКТИВНА ТЕРАПИЯ ПЕРВОЙ ЛИНИИ АНТИ-TNFα | |
| RU2014150942A (ru) | Лечение побочных эффектов в виде моторных и двигательных расстройств, связанных с лечением болезни паркинсона | |
| BR112014012054A2 (pt) | métodos de tratamento com deferiprona | |
| EA201300421A1 (ru) | Комбинированная терапия для лечения инфекции hcv | |
| EA201270071A1 (ru) | Способ лечения пациента, нуждающегося в аспириновой терапии | |
| DK1689404T3 (da) | Kombination af et-743 med 5-fluoracil-prodrugs til behandling af cancer | |
| MY134562A (en) | Methods and compositions to treat conditions associated with neovascularization | |
| MX2022016406A (es) | Metodos para tratar el cancer o enfermedad de von-hippel lindau usando una combinacion de un inhibidor de hif-2 alpha y lenvatinib. | |
| CY1118486T1 (el) | Λαπατινιμπη για τη θεραπεια του καρκινου | |
| NZ592613A (en) | Method for treating or preventing thrombosis using >150 mg to 300 mg b.i.d. of dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy | |
| EA201270747A1 (ru) | Композиции и способы для профилактики и лечения ран | |
| ATE405263T1 (de) | Anti-hiv-chinuklidinverbindungen | |
| DE602004030048D1 (de) | Ffizienz | |
| CL2021003303A1 (es) | Tratamiento para sinucleinopatías. | |
| MX2022016410A (es) | Metodos para tratar el cancer o enfermedad de von-hippel lindau usando una combinacion de un antagonista del pd-1, inhibidor de hif-2 alpha y lenvatinib o una sal aceptable farmeuticamente de estos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |